What does it mean if Lyrica (pregabalin) raises liver enzymes?
Lyrica (pregabalin) isn’t mainly known for causing clinically significant liver injury, but liver test abnormalities can still occur. If liver enzymes rise after starting Lyrica, the key clinical question is whether the pattern looks mild and transient or instead suggests clinically meaningful drug-related liver injury (for example, marked enzyme elevations or signs of liver dysfunction).
Because the right action depends on how high the enzymes are and whether symptoms are present, the safest approach is usually to reassess dosing and causes rather than automatically stopping.
Should Lyrica be stopped just for “elevated liver enzymes”?
In practice, clinicians typically manage elevated liver enzymes by considering both:
- How high the values are (severity).
- Whether there are symptoms or signs of liver dysfunction (for example, jaundice, dark urine, significant fatigue, abdominal pain, itching, vomiting, or unusual bleeding).
If the elevation is small and the patient feels well, clinicians commonly repeat labs, look for other causes (alcohol use, viral hepatitis, fatty liver, other medications/supplements), and monitor while deciding whether to continue or hold Lyrica.
If enzyme levels are significantly elevated or the patient has symptoms suggesting liver injury, discontinuation (or at least interruption) is generally considered the safer course and the medication should not be resumed without medical guidance.
What levels are “concerning” enough to discontinue?
The usual decision points come from standard hepatology thresholds used in drug-induced liver injury evaluation:
- Marked transaminase elevations (often several times the upper limit of normal).
- Evidence of impaired liver function, especially if bilirubin is elevated (a more serious signal than enzyme rise alone).
- Any combination of enzyme elevation plus symptoms consistent with hepatitis or cholestasis.
Your clinician will interpret LFTs in context (AST, ALT, alkaline phosphatase, bilirubin, INR if available) rather than relying on “elevated enzymes” alone.
Could the elevated enzymes be from something else?
Yes. Elevated liver enzymes after starting any medication can also reflect unrelated liver conditions or interactions. Common alternatives to check include:
- Viral hepatitis or recent infection
- Alcohol-related liver injury
- Fatty liver disease
- Biliary obstruction or other liver/gallbladder disease
- Other prescription drugs (including antibiotics, anticonvulsants, and statins) and herbal supplements
This is why workup and repeat testing often matter more than the medication name alone.
What should patients do now?
Patients should not stop Lyrica on their own without speaking to the prescriber, but they should contact their doctor promptly to:
- Review the exact LFT results (AST/ALT/ALP/bilirubin) and the trend.
- Assess symptoms of liver problems.
- Determine whether to temporarily hold the dose, reduce it, or continue with close monitoring.
- Decide whether additional testing is needed (repeat LFTs, hepatitis testing, coagulation tests, ultrasound, etc.).
If symptoms like jaundice, dark urine, severe fatigue, or right-upper-abdominal pain are present, urgent medical evaluation is more appropriate.
Are there Lyrica dosing alternatives if LFTs stay elevated?
If the decision is made to continue, clinicians may adjust dose and monitor more closely. If Lyrica is discontinued due to suspected liver injury, prescribers may switch to an alternative for the underlying condition (pain/neuropathy, seizures, etc.), depending on why the patient is taking it.
Sources
No reliable source about specific “discontinue vs continue” thresholds for Lyrica-related liver enzyme elevations was provided in the information available to me here.